Assignee
ALTAVANT SCIENCES GMBH
CH·8 granted patents·12 pending applications·13 citations·filing 2019–2023
Top patents by PatentIndex Score
20 records- 0189US11759462B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsALTAVANT SCIENCES GMBH·Filed 2021·Granted Sep 19, 2023·1 cites·24 claims
- 0287US11911382B2Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertensionALTAVANT SCIENCES GMBH·Filed 2022·Granted Feb 27, 2024·1 cites·8 claims
- 0387US11091763B2Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitorsALTAVANT SCIENCES GMBH·Filed 2019·Granted Aug 17, 2021·1 cites·20 claims
- 0485US11576915B2Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension and daily dosingALTAVANT SCIENCES GMBH·Filed 2020·Granted Feb 14, 2023·2 cites·23 claims
- 0585US11413287B2Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertensionALTAVANT SCIENCES GMBH·Filed 2019·Granted Aug 16, 2022·3 cites·11 claims
- 0679US11203597B2Crystalline spirocyclic compound, a dosage form containing, a method for using in treatment of disease, and a method for recrystallizingALTAVANT SCIENCES GMBH·Filed 2019·Granted Dec 21, 2021·3 cites·12 claims
- 0776US11607413B2Dosage regime and method for treating pulmonary arterial hypertensionALTAVANT SCIENCES GMBH·Filed 2020·Granted Mar 21, 2023·2 cites·28 claims
- 0865US2024024316A1Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension and daily dosingALTAVANT SCIENCES GMBH·Filed 2023·Application pending·0 cites
- 0964US11708365B2Processes for preparing TPH1 inhibitorsALTAVANT SCIENCES GMBH·Filed 2021·Granted Jul 25, 2023·0 cites·25 claims
- 1063US2022047594A1Method for treating interstitial lung diseaseALTAVANT SCIENCES GMBH·Filed 2021·Application pending·0 cites
- 1162US2020188399A1Method for treating interstitial lung diseaseALTAVANT SCIENCES GMBH·Filed 2019·Application pending·0 cites
- 1258US2020188398A1Method for treating sarcoidosis-associated pulmonary hypertensionALTAVANT SCIENCES GMBH·Filed 2019·Application pending·0 cites
- 1358US2024041877A1Dosage regime and method for treating pulmonary arterial hypertensionALTAVANT SCIENCES GMBH·Filed 2023·Application pending·0 cites
- 1458US2019263815A1Processes for preparing tph1 inhibitorsALTAVANT SCIENCES GMBH·Filed 2019·Application pending·0 cites
- 1556US2022096475A1Method for treating sarcoidosis-associated pulmonary hypertensionALTAVANT SCIENCES GMBH·Filed 2021·Application pending·0 cites
- 1653US2022073516A1Crystalline spirocyclic compound, a dosage form containing, a method for using in treatment of disease, and a method for recrystallizingALTAVANT SCIENCES GMBH·Filed 2021·Application pending·0 cites
- 1749US2022339099A1Compositions of interleukin-1 receptor antagonistALTAVANT SCIENCES GMBH·Filed 2022·Application pending·0 cites
- 1842US2022409627A1Treatment of lower airways disordersALTAVANT SCIENCES GMBH·Filed 2020·Application pending·0 cites
- 1941US2023074252A1Dosages and methods for treating pulmonary arterial hypertension with rodatristatALTAVANT SCIENCES GMBH·Filed 2021·Application pending·0 cites
- 2039US2023210768A1An inhaled il-1 blockade treatment for respiratory tract immunopathologyALTAVANT SCIENCES GMBH·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →